Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes
Nathaniel A. Cohen, Joshua M. Steinberg, Alexa Silfen, Cindy Traboulsi, Tina Rodriguez, Jorie Singer, Shivani Patel, Russell D. Cohen, Sushila Dalal, Atsushi Sakuraba, Joel Pekow, Dejan Micić, David T. Rubin
Topics & Concepts
TofacitinibMedicineDiscontinuationUlcerative colitisInternal medicineAdverse effectInflammatory bowel diseaseHepatologyInterquartile rangeColectomyPouchitisGastroenterologyRetrospective cohort studyCalprotectinSurgeryRheumatoid arthritisDiseaseInflammatory Bowel DiseaseClostridium difficile and Clostridium perfringens researchMicroscopic Colitis